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were measured by ELISE. Left ventricular ejection fraction (LVEF) by
echocardiography, LVMI and MWS were calculated.
RESULTS The level of Serum HMGB1 and LVMI, MWS in CHF patients
lived at high altitude were higher than those at moderate altitude
[(42.877.86) pg/ml vs (26.755.22) pg/ml, (189.79.5) vs (96.38.4)
g/m2 and (476.214.9) vs (304.713.5) dynes x103/cm2, respectively,
all p<0.01].and the level of Fetuin-A was on the contrary [(1.15 0.32)
g/L vs ( 2.38 0.56) g/L, p<0.01]. It was found that LVMI, MWS has a
positive correlation withthe level of HMGB1 (P<0.01), and a negative
correlation With the level of Fetuin-A (P<0.01).
CONCLUSIONS ventricular remodeling in CHF change With the alti-
tude level severely. The changes LVMI and MWS were more related to
higher level of HMGB1 and lower level of Fetuin-A. At high altitude,
increasing in the level of HMGB1 and decreasing in the level of Fetuin-
A play roles in pathophysiological and pathogenetic mechanism of
ventricular remodeling in CHF, and correlated with the severity de-
gree of ventricular remodeling in CHF.
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The relationship between bone mineral density and left ventricular
diastolic function in elderly hypertension patients
Zhiheng Chen, Pengqiang Zhang
the second afﬁliated hospital of Dalian Medical University
OBJECTIVES To investigate the relationship between bone mineral
density and left ventricular diastolic function in elderly hypertension
patients.
METHODS Retrospective analysis was performed in 1002 consecutive
hypertension patients, aged over 60, who were admitted to the sec-
ond afﬁliated hospital of Dalian Medical University from December
2013 to February 2015. Bone mineral density (BMD) was measured by
dual X-ray absorptiometry and detected results were shown by T
scores averaged for all four parts. All cases were divided into three
groups based on T scores: Normal bone mass group (n¼269): T-1.0;
Osteopenia group (n¼433): -2.5<T<-1.0; and Osteoporosis group
(n¼300): T-2.5. In order to evaluate the left ventricular diastolic
function in patients, the echocardiogram was used to measure the
early diastolic peak velocity (E) and late diastolic peak velocity (A) of
left ventricle, and then calculate the E/A ratio. E/A 1.0 represents left
ventricular diastolic dysfunction (LVDD), which can be used to assess
the changes in LVDD and to evaluate the relationship with BMD.
ANOVA was applied to analyze the mean of the E/A ratio and Chi-
square test was used to compare LVDD incidence among the indicated
three groups. All cases were divided into two groups based on E/A
ratio. Normal left ventricular diastolic function group (n¼506), E/
A>1;left ventricular diastolic dysfunction group (n¼496), E/A 1.0.
Chi-square test was used to compare abnormal incidence of BMD
between the two groups. Simple linear correlation was used to analyze
the correlation of E/A ratio with each factor. Multiple linear regression
analysis was applied to analyze the independent factors of E/A ratio.
P<0.05 was considered statistically signiﬁcant.
RESULTS 1.The incidence of LVDD of Osteoporosis group (56.3%) was
signiﬁcantly higher than that of Normal bone mass group (44.2%) as
well as Osteopenia group (48%) (p<0.05). And there was no signiﬁcant
difference between Osteopenia group and Normal bone mass group
(p>0.05). The abnormal incidence of BMD of LVDD group (76%) was
higher than normal left ventricular diastolic function group (p<0.05).
2. Reduced BMD of the femoral neck (r¼0.102, p¼0.001) and
increased total cholesterol (r¼-0.067, p¼0.035) both were recognized
as independent variables of LVDD in multinomial regression analysis.
CONCLUSIONS 1. The incidence of LVDD of Osteoporosis group is
signiﬁcantly higher than that of Normal bone mass group. The
abnormal incidence of BMD of LVDD in elderly hypertension patients
is higher than that of normal left ventricular diastolic function.
2. Reduced BMD of the femoral neck and increased total cholesterol
both are recognized as independent variables of LVDD, which can be
referred to be important predictive factors in assessment and evalu-
ation of cardiovascular events.
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The predictable between CAl25 and the rehospitalization rate in CHF patients
Rui Ma
Mengcheng Hospital of Traditional Chinese Medicine
OBJECTIVES To study the relationship between CA 1 25 and the
rehospitalization rate in CHF patients.METHODS 145 patients with CHF were divided into three groups
based on the standard of NYHA.classiﬁcation. The subgroup were
divided according CAl25 levels(35 U / m1) and BNP levels(400 pg / m1).
After 1-.6 months follow-up, the endpoints, mortality and CHF reho-
spitalization were analyzed according the level of CAl25 and BNP.
RESULTS The higher the SeDlm of CAl25, the higher NYHA functional
class[I / 1I(18. 795. 23)U / ml, llI(82. 34_þ24. 37)U / ml, IV(187, 4037.
42)U / ml, P<O. 05], the rate of rehospitalization in patients with CHF
was higher with the increase of selxlm CAl25(P20. 01 1) and BNP(P20.
001). The combination CAl25 with BNP showed more accurately pre-
dictable value of CHF rehospitalization(P¼O. 00012).
CONCLUSIONS Serum levels of CAl25 are associated with the severity
of CHF, which can prognosis the rehospitalization in CHF patients.
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The relation of between pulmonary hypertension and diastolic function in
patients with left ventricular systolic dysfunction
Sang-Hoon Seol, Guang-Won Seo, Pil-Sang Song, Dong-Kie Kim,
Doo-Il Kim
Haeundae Paik hospital
OBJECTIVES Pulmonary hypertension (PH) secondary to left ven-
tricular systolic dysfunction (LVSD) is often a poor prognosis marker
in chronic heart failure. Diastolic ﬁlling pressure abnormalities have
been described in patients with severe PH. The aim of our study was
to assess between diastolic function and PH associated LVSD.
METHODS 425 patients with LV Ejection fraction(EF) 40% were
divided into two groups according to the PH. PH estimated with the
right ventricular systolic pressure. PH was deﬁned systolic pulmonary
artery pressure (PAP) > 45 mmHg at rest. Diastolic parameters
(transmitral ﬂow velocity (E)/mitral annular velocity (e0), mitral valve
deceleration time (DT) and left atrium diameter (LAD) were evaluated.
RESULTS 135 patients had PH, whereas 290 patients had normal. Pa-
tients with PH were with higher E/e0 ratio, lower DT and increased
LAD. In multiple regression analysis, PAP was signiﬁcantly correlated
with E/e0 ratio, DT, gender and LAD. In multivariate analysis, E/e0
ratio> 15(odds ratio: 3.5, P<0.001), LAD (>4.2 cm in male, >3.8 cm in
female) (odds ratio: 2.2, P<0.001), female (odds ratio: 2.1, P¼0.003)
were the independent risk factors for PH in patients with LVSD.
CONCLUSIONS The diastolic echocardiographic parameters may be
important predictors for PH in patients with LVSD.
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Prognostic role of serum C-reactive protein in chronic heart failure: a
systematic review and meta-analysis
Liping Wang, Yong Han, Shanshan Zhou
Department of Internal Medicine-Cardiovascular, Hong Hui Hospital,
Xi’an Jiaotong University College of Medicine, Xi’an, China
OBJECTIVES To aim at investigating serum C-reactive protein (CRP),
a marker of systemic inﬂammation, its role as a prognostic marker in
patients with chronic heart failure (CHF).
METHODS We searched Medline and EMBASE for prospective studies
of patients with CHF that reported clinical outcomes according to
serum CRP levels. A meta-analysis was performed to assess the as-
sociation between CRP levels and prognoses in patients with CHF.
RESULTS A total of eight studies involving 6018 patients were
included in our study. Mean level of CRP was 3.27mg/L at baseline.
Long term follow-up varied from 1 year to 8.7 years. Our pooled re-
sults demonstrated that a high level of CRP was a predictor of mor-
tality (Hazard ratio: 1.86; 95% CI: 1.33 to 3.59; P<0.001) and major
adverse cardiac events (MACE) (Hazard ratio: 2.87, 95% CI: 1.64 to
4.62; P<0.001) in multivariate analysis.
CONCLUSIONS Levels of CRP have predictive value in long term
mortality and MACE of patients with CHF.
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Efﬁcacy of Recombinant Human Brain Natriuretic Peptide in acute
decompensated ischemic heart failure
Zhijun Zhu, Danning Wu
The ll7th Hospital of PLA
OBJECTIVES To explore the clinical efﬁcacies of recombinant human
brain natriuretic peptide(rhBNP) in patients with acute decom-
pensated ischemic heart failure.
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poor effect by routine digitalis, diuretic and nitroglycerin therapy,
were recruited into our centre, then were divided into 2 groups
randomly: rhBNP therapy group (n¼31), milrinone therapy
group(n¼31). The frequency of breathing and heart beating, the grade
of NYHA heart function, left ventricular ejection fraction (LVEF), and
the centre venous pressure (CVP), of the patients were observed. The
level of creatinine, alanine aminotransterase (ALT) and NT-proBNP
were measured.
RESULTS The descending frequency of heart beating, the descending
amplitude of the level of creatinine and NT-proBNP, of rhBNP group
were higher than that of milrinone group respectively (25.68.7)
beating/min, (18.57.3) beating/min (p <0.05); (68.211.8)mmol / L,
(46.410.9)mmol / L (p <0.01); (687.7221.5) ng / L, (430.4170.9)ng /
L (p <0.01). The elevating amplitude of the LVEF of rhBNP
group also were higher than that of milrinone group respectively
(8.14.7)%,(5.53.3)%(p <0.05)0. There were no difference in the
altered levels of alanine aminotransterase, the descending
amplitude of CVP, the descending frequency of breathing, and the
descending grade of NYHA heart function, between two groups
respectively (56.410.3) u/l,(47.812.6) u/l (p >0.05);(5.43.3)
cmH2O,(4.02.8)cmH2O (p>0.05); (15.18.7)/min,(12.59.3)/min
(p>0.05);(1.30.3),(1.00.4) (p >0.05).
CONCLUSIONS The rhBNP is efﬁcacy and safe for acute decom-
pensated ischemic heart failure.
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Evaluating the effectiveness of carvedilol on the beta-adrenoreceptor
dencity in patients with chronic heart failure
Umida Kamilova,1,2 Tohira Alieva1,2
1Republican Specialized Scientiﬁc-Practical Medical Center of Therapy
and Medical Rehabilitation; 2Tashkent Medical academy
OBJECTIVES The purpose of this study was to evaluate the effect of
carvedilol on b2-adrenoceptor density in erythrocyte membranes of
post-MI patients with chronic heart failure (CHF).
METHODS The study included 56 post-MI male patients aged from 45
to 55 (mean age 51.24.6 years) years with CHF FCII-III; duration of
post-MI period was 2.30.9 years. All the patients were divided into
two groups according to the New York Heart Classiﬁcation (NYHA)
functional class (FC). Group 1 consisted of 30 post-MI patients with
CHF FC-II and Group 2 consisted of 26 post-MI patients with CHF-III.
The b2-adrenoceptor density in erythrocyte membranes was deter-
mined using b-APM-AGAT kits. All patients received a carvedilol,
nonselective beta blocker with a1-, b1- and b2- blocking properties, on
the background of basic therapy (ACE inhibitors, spironolactone, ni-
trates, aspirin, loop diuretics). Initial carvedilol dosage was 3.125 mg
and was titrated to achieve the target dosage of 25–50 mg twice a day.
Mean carvedilol dosage was 23.84.6 mg/day in Group 1 and
33.656.9 mg/day in Group II. Exclusion criteria were diabetes, heart
rhythm disorders, COPD, asthma, and acute stroke.
RESULTS In Group 1 patients, the initial erythrocyte b2-adrenoceptor
density was 27.71.4CU and exceeded the control value group by 2.4
times; in Group 2 patients it was 30.81.3CU and exceeded the control
value by 2.9 times. Our studies have shown that therapy with carve-
dilol for 6 months led to a decrease of b2-adrenoceptor density by
15.7% (P<0.05) in post-MI patients with CHF FC-II and by 22.7%
(P<0.05) in post-MI patients with CHF FC-III in comparison with the
initial levels.
CONCLUSIONS In conclusion, in post-MI patients with CHF FC I-III,
the increased b2-adrenoceptor density, which is more pronounced in
patients of Group 2. Long-term therapy with carvedilol reduces the b2-
adrenoceptor density in erythrocyte membranes of post-Mi patients
with CHF FCII-III.
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The Clinical Observation of Cardiac Resynchronization Therapy in Patients
with Chronic Heart Failure
Dongming Xie, Jiayuan Lin, Yihong Yang, Zhanglin Yan,
Xiangzhong Liao, Xufeng Zhou, Jiumei Cai, Gulao Zhang, Shike Luo,
Zuofeng Cao, Yuping Lin, Wenting Zhong, Xinguang Chen,
Haiying Chang, He Huang, Mei Zhong, Jinhai Zhu, Bei Wang, Ping Lai,
Kun Xiao
the ﬁrst afﬁliated hospital of GanNan Medical collage
OBJECTIVES To explore the clinical effects of Cardiac resynchroni-
zation therapy (CRT) in patients with chronic heart failure.METHODS 6 cases which received CRT by cardiology department 2
from January 2014 to January 2015 were selected, 4 cases with dilated
cardiomyopathy, 2 cases with ischemic cardiomyopathy; 5 cases were
males and 1 case were female; 5 cases with left bundle branch
block(LBBB);mean range was 52-70 years. Inclusion criteria:
1. after optimization drug treatment, the heart of New York (NAHY)
levels were still at III to IV;
2. left ventricular end diastolic diameter (LVEDd)55mm, left ventric-
ular ejection fraction(LVEF)35%;
3. the ventricular wall have were incoordination;
4. QR S duration 120 ms;
5. sinus rhythm.
The medical history of the patients with heart failure were greater
than 1 year, and the symptom of heart failure were still 6 existing after
drug treatment. 5 cases NYHA class were III, 1 case was IV. The
pacemaker wires inserted in auricula dextra, right ventricular apex,
Coronary sinus collateral or dexterramus through left subclavian vein.
The implantation left ventricular pacing lead: To understand the di-
rection of blood vessels by using coronary sinus imaging, and choose
the best location according to the results of the pacemaker parameters
and imaging.The pacemaker wires inserted in collateral or back of the
coronary sinus, the pacing thresholds were satisﬁed. Then, the right
ventricle and right atrium wires were inserted, and to test the Pace-
maker threshold and perception parameters. Lastly, the pacemaker
wires were connected to pacemaker, and the pacemaker was
implanted in the left side of pectoralis major., and sew up the incision.
The A-V period and V-V period were optimized after 1 week, 1 month,
3 month, 6 month, 12 month. To observe the cardiac function, QRS
duration, LVEF, LVEDd after 64.3 month follow-up. Using SPSS13.0
software for statistical analysis, measurement data said with 0xs, and
then compared by t-test, P < 0.05 for statistical signiﬁcance.
RESULTS The implantations of CRT were successful, and the NYHA
class were great improvement from III - IV to I-II (p <0.05), the QRS
duration was signiﬁcant decreased from 14912.4ms to 117.24.8ms
(p <0.05), the LVEF was great improved from 0.280.06 to 0.480.06
(p <0.05), and the LVEDd was signiﬁcant decreased from 69.96.4mm
to 51.06.7mm, (p <0.01).
CONCLUSIONS The cardiac resynchronization therapy conbine drug
treatment could improve cardiac function, alleviate clinical symptoms
in patients with chronic heart failure, and improve the patient’s
quality of life.
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The Correlation of PI3K/Akt Signaling Pathway with the Occurrence of
Cardiac Cachexia
Xin Zhang, Qinmei Fan
The second cardiological department of the ﬁrst afﬂicated hospital of
Baotou medical college, Bao Tou, Inner Mongolia, 014010
OBJECTIVES To explore whether the phosphoinositide 3-kinase /
protein kinase B (PI3K/AKT) signaling pathway was related to the
occurrence of isoproterenol (ISO) induced Cardiac Cachexia.
METHODS One hundred male Sprague-Dawey rats were randomly
divided into ISO group and control group. In ISO group, the rats were
administered with ISO of 180mg/kg$d via inguinal subcutaneous in-
jection, once every other day, 2 times in all. After 4 weeks, the heart
function of was measured by echocardiography. All rats were
weighted before injecting ISO and after 4 weeks. According to the
changes of body weight and the echocardiography results, ISO group
were divided into cardiac cachexia group (n¼29) and heart failure non
cachexia group (n¼40). The levels of total protein, triglycerides,
cholesterol and blood glucose were detected by using automatic
biochemical analyzer. The levels of insulin and Insulin-like growth
factor-1 (IGF-1) in the serum of all rats were detected by enzyme-
linked immunosorbent assay (ELISA); the expression of p85, p-Akt
and NF-kB in the myocardial tissue were detected by immunohisto-
chemical; the expression of caspase9 mRNA and Bcl-xl mRNA in the
myocardial tissue were detected by reverse transcription polymerase
chain reaction (RT-PCR).
RESULTS (1) The levels of LVEDD, LVESD increased signiﬁcantly and
LVEF, FS decreased signiﬁcantly in ISO group(P <0.05) (2) the levels
of total protein, blood glucose decreased signiﬁcantly and tri-
glycerides, cholesterol increased signiﬁcantly in ISO group compared
with control group (P <0.05) (3) the levels of insulin in cardiac
cachexia group(30.85þ1.90 mIU/L) was signiﬁcantly higher than in the
heart failure non cachexia group(19.56þ5.33 mIU/L) and control group
(27.45þ5.36 mIU/L) (P <0.05), (4) the levels of IGF-1 in cardiac
